|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.260 USD | -0.19% |
|
+3.34% | -12.77% |
| 06-08 | Savara Inc. Announces CFO Changes | CI |
| 06-08 | Savara Inc. Announces Step Down of Dave Lowrance as Chief Administrative Officer, Effective July 15, 2026 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Specialty Pharmaceuticals within The Respiratory System | - | - | - | - | - | |||||
Total Assets | 177M | 140M | 178M | 213M | 253M | |||||
Interest Expense | -2.28M | -88K | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
CAPEX | -57K | -9K | -296K | -25K | -22K | |||||
EBT | -43.01M | -38.15M | -54.7M | -95.88M | -119M | |||||
D&A | 367K | 167K | 175K | 275K | 245K | |||||
Operating Income | -41.48M | -38.84M | -60.01M | -103M | -124M | |||||
Net Income | -43.01M | -38.15M | -54.7M | -95.88M | -119M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | - | - | - | - | - | |||||
Total Assets | 177M | 140M | 178M | - | 253M | |||||
Interest Expense | -2.28M | -88K | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
D&A | 367K | 167K | 175K | - | 245K | |||||
CAPEX | -57K | -9K | -296K | - | -22K | |||||
Net Income | -43.01M | -38.15M | -54.7M | - | -119M | |||||
EBT | -43.01M | -38.15M | -54.7M | - | -119M | |||||
Operating Income | -41.48M | -38.84M | -60.01M | - | -124M |
- Stock Market
- Stocks
- SVRA Stock
- Financials Savara Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition